Postpartum Haemorrhage Treatment Device Market is expected to reach US$ 1.66 Bn. at a CAGR of 5.2% during the forecast period 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report Global postpartum haemorrhage treatment device market is segmented by types, application, and region.By types, global market is classified into non-pneumatic anti-shock garment, uniject prefilled injection system, uterine balloon tamponade, and other. Based on application, global market is divided into hospitals, clinics, and others. By geographically, global market is divided into North America, Europe, Asia-pacific, South America and Middle East & Africa. Increasing government educational initiatives and training about women’s health is driving the growth in market. Rising awareness among people in developing countries for postpartum treatment, an increasing rate of postpartum haemorrhage, and proliferation in postpartum haemorrhage risk factors are boosting the market growth. Technological advancements in postpartum haemorrhage treatment devices are also propelling the market growth. Slow adoption of novel PPH treatments & devices owing to the high price factor is negatively impacting the market growth. Uterine balloon tamponade is a simple and effective second-line intervention treatment for PPH. Uterine is a medical device used to treat postpartum haemorrhage which is unresponsive to uterotonics and other primary interventions. Factors driving uterine balloon tamponade segment are the ultra-low cost, high effectiveness, and easy availability of uterine balloon tamponade. North America is expected to account for the largest market share of the global market owing to the growing rate of maternal mortality and increasing regency complications. Asia Pacific is expected to be a key market for PPH treatment devices owing to the growing occurrence of postpartum haemorrhage cases. Major players in the postpartum haemorrhage treatment device market are BD, GE Healthcare, Bactiguard, R. Bard, Cook Medical, Davol, 3rd Stone Design, Teleflex Incorporated, Utah Medical Products, Program for Appropriate Technology In Health (Path), Zoex Niasg, and Inpress Technologies.
The Scope of Global Postpartum Haemorrhage Treatment Device Market: Inquire before buying
Global Postpartum Haemorrhage Treatment Device Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 5.2% US$ 1.16 Bn US$ 1.66 Bn Segments Covered by Type Non-pneumatic Anti-shock Garment Uniject Prefilled Injection System Uterine Balloon Tamponade Other by Application Hospitals Clinics Other Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Postpartum Haemorrhage Treatment Device Market Key Players are:
1.BD 2.GE Healthcare 3.Bactiguard 4.R. Bard 5.Cook Medical 6.Davol 7.3rd Stone Design 8.Teleflex Incorporated 9.Utah Medical Products 10.Program for Appropriate Technology In Health (Path) 11.Zoex Niasg 12.Inpress Technologies 13.Vitality Medical 14.Revmedx Inc. 15.Alydia Health 16.Sterimed Group 17.Angiplast 18.Sara Health Care 19.Boen Healthcare Co., Ltd 20.McKesson Medical-Surgical Inc. Frequently Asked questions 1. What is the market size of the Global Postpartum Haemorrhage Treatment Device Market in 2022? Ans. The market size Global market in 2022 was US$ 1.16 Billion. 2. What are the different segments of the Global Postpartum Haemorrhage Treatment Device Market ? Ans. The Global market is divided into Types and Application. 3. What is the study period of this market? Ans. The Global market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Postpartum Haemorrhage Treatment Device Market ? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Postpartum Haemorrhage Treatment Device Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Postpartum Haemorrhage Treatment Device Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.4.Global Postpartum Haemorrhage Treatment Device Market Industry Trends 5. Global Postpartum Haemorrhage Treatment Device Market Analysis and Forecast 5.1. Global Postpartum Haemorrhage Treatment Device Market Analysis and Forecast 5.2. Global Postpartum Haemorrhage Treatment Device Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. South America 6. Global Postpartum Haemorrhage Treatment Device Market Analysis and Forecast, by Types 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Types 6.4. Global Postpartum Haemorrhage Treatment Device Market Size (US$ Mn) Forecast, by Types 6.5. Global Postpartum Haemorrhage Treatment Device Market Analysis, by Types 6.6. Global Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis, by Types 7. Global Postpartum Haemorrhage Treatment Device Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Application 7.3. Global Postpartum Haemorrhage Treatment Device Market Size (US$ Mn) Forecast, by Application 7.4. Global Postpartum Haemorrhage Treatment Device Market Analysis, by Application 7.5. Global Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis, by Application 8. Global Postpartum Haemorrhage Treatment Device Market Analysis, by Region 8.1. Global Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Region 8.2. Global Postpartum Haemorrhage Treatment Device Market Size (US$ Mn) Forecast, by Region 8.3. Global Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis, by Region 9. North America Postpartum Haemorrhage Treatment Device Market Analysis 9.1. Key Findings 9.2. North America Postpartum Haemorrhage Treatment Device Market Overview 9.3. North America Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Types 9.4. North America Postpartum Haemorrhage Treatment Device Market Forecast, by Types 9.4.1. Non-pneumatic Anti-shock Garment 9.4.2. Uniject Prefilled Injection System 9.4.3. Uterine Balloon Tamponade 9.4.4. Other 9.5. North America Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Application 9.6. North America Postpartum Haemorrhage Treatment Device Market Forecast, by Application 9.6.1. Hospitals 9.6.2. Clinics 9.6.3. Other 9.7. North America Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Country 9.8. North America Postpartum Haemorrhage Treatment Device Market Forecast, by Country 9.8.1. U.S. 9.8.2. Canada 9.9. North America Postpartum Haemorrhage Treatment Device Market Analysis, by Country 9.10. U.S. Postpartum Haemorrhage Treatment Device Market Forecast, by Types 9.10.1. Non-pneumatic Anti-shock Garment 9.10.2. Uniject Prefilled Injection System 9.10.3. Uterine Balloon Tamponade 9.10.4. Other 9.11. U.S. Postpartum Haemorrhage Treatment Device Market Forecast, by Application 9.11.1. Hospitals 9.11.2. Clinics 9.11.3. Other 9.12. Canada Postpartum Haemorrhage Treatment Device Market Forecast, by Types 9.12.1. Non-pneumatic Anti-shock Garment 9.12.2. Uniject Prefilled Injection System 9.12.3. Uterine Balloon Tamponade 9.12.4. Other 9.13. Canada Postpartum Haemorrhage Treatment Device Market Forecast, by Application 9.13.1. Hospitals 9.13.2. Clinics 9.13.3. Other 9.14. North America Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis 9.14.1. By Types 9.14.2. By Application 9.15. PEST Analysis 10. Europe Postpartum Haemorrhage Treatment Device Market Analysis 10.1. Key Findings 10.2. Europe Postpartum Haemorrhage Treatment Device Market Overview 10.3. Europe Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Types 10.4. Europe Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.4.1. Non-pneumatic Anti-shock Garment 10.4.2. Uniject Prefilled Injection System 10.4.3. Uterine Balloon Tamponade 10.4.4. Other 10.5. Europe Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Application 10.6. Europe Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.6.1. Hospitals 10.6.2. Clinics 10.6.3. Other 10.7. Europe Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Country 10.8. Europe Postpartum Haemorrhage Treatment Device Market Forecast, by Country 10.8.1. Germany 10.8.2. U.K. 10.8.3. France 10.8.4. Italy 10.8.5. Spain 10.8.6. Rest of Europe 10.9. Europe Postpartum Haemorrhage Treatment Device Market Analysis, by Country/ Sub-region 10.10. Germany Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.10.1. Non-pneumatic Anti-shock Garment 10.10.2. Uniject Prefilled Injection System 10.10.3. Uterine Balloon Tamponade 10.10.4. Other 10.11. Germany Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.11.1. Hospitals 10.11.2. Clinics 10.11.3. Other 10.12. U.K. Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.12.1. Non-pneumatic Anti-shock Garment 10.12.2. Uniject Prefilled Injection System 10.12.3. Uterine Balloon Tamponade 10.12.4. Other 10.13. U.K. Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.13.1. Hospitals 10.13.2. Clinics 10.13.3. Other 10.14. France Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.14.1. Non-pneumatic Anti-shock Garment 10.14.2. Uniject Prefilled Injection System 10.14.3. Uterine Balloon Tamponade 10.14.4. Other 10.15. France Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.15.1. Hospitals 10.15.2. Clinics 10.15.3. Other 10.16. Italy Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.16.1. Non-pneumatic Anti-shock Garment 10.16.2. Uniject Prefilled Injection System 10.16.3. Uterine Balloon Tamponade 10.16.4. Other 10.17. Italy Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.17.1. Hospitals 10.17.2. Clinics 10.17.3. Other 10.18. Spain Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.18.1. Non-pneumatic Anti-shock Garment 10.18.2. Uniject Prefilled Injection System 10.18.3. Uterine Balloon Tamponade 10.18.4. Other 10.19. Spain Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.19.1. Hospitals 10.19.2. Clinics 10.19.3. Other 10.20. Rest of Europe Postpartum Haemorrhage Treatment Device Market Forecast, by Types 10.20.1. Non-pneumatic Anti-shock Garment 10.20.2. Uniject Prefilled Injection System 10.20.3. Uterine Balloon Tamponade 10.20.4. Other 10.21. Rest of Europe Postpartum Haemorrhage Treatment Device Market Forecast, by Application 10.21.1. Hospitals 10.21.2. Clinics 10.21.3. Other 10.22. Europe Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis 10.22.1. By Types 10.22.2. By Application 10.23. PEST Analysis 11. Asia Pacific Postpartum Haemorrhage Treatment Device Market Analysis 11.1. Key Findings 11.2. Asia Pacific Postpartum Haemorrhage Treatment Device Market Overview 11.3. Asia Pacific Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Types 11.4. Asia Pacific Postpartum Haemorrhage Treatment Device Market Forecast, by Types 11.4.1. Non-pneumatic Anti-shock Garment 11.4.2. Uniject Prefilled Injection System 11.4.3. Uterine Balloon Tamponade 11.4.4. Other 11.5. Asia Pacific Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Application 11.6. Asia Pacific Postpartum Haemorrhage Treatment Device Market Forecast, by Application 11.6.1. Hospitals 11.6.2. Clinics 11.6.3. Other 11.7. Asia Pacific Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Country 11.8. Asia Pacific Postpartum Haemorrhage Treatment Device Market Forecast, by Country 11.8.1. China 11.8.2. India 11.8.3. Japan 11.8.4. ASEAN 11.8.5. Rest of Asia Pacific 11.9. Asia Pacific Postpartum Haemorrhage Treatment Device Market Analysis, by Country/ Sub-region 11.10. China Postpartum Haemorrhage Treatment Device Market Forecast, by Types 11.10.1. Non-pneumatic Anti-shock Garment 11.10.2. Uniject Prefilled Injection System 11.10.3. Uterine Balloon Tamponade 11.10.4. Other 11.11. China Postpartum Haemorrhage Treatment Device Market Forecast, by Application 11.11.1. Hospitals 11.11.2. Clinics 11.11.3. Other 11.12. India Postpartum Haemorrhage Treatment Device Market Forecast, by Types 11.12.1. Non-pneumatic Anti-shock Garment 11.12.2. Uniject Prefilled Injection System 11.12.3. Uterine Balloon Tamponade 11.12.4. Other 11.13. India Postpartum Haemorrhage Treatment Device Market Forecast, by Application 11.13.1. Hospitals 11.13.2. Clinics 11.13.3. Other 11.14. Japan Postpartum Haemorrhage Treatment Device Market Forecast, by Types 11.14.1. Non-pneumatic Anti-shock Garment 11.14.2. Uniject Prefilled Injection System 11.14.3. Uterine Balloon Tamponade 11.14.4. Other 11.15. Japan Postpartum Haemorrhage Treatment Device Market Forecast, by Application 11.15.1. Hospitals 11.15.2. Clinics 11.15.3. Other 11.16. ASEAN Postpartum Haemorrhage Treatment Device Market Forecast, by Types 11.16.1. Non-pneumatic Anti-shock Garment 11.16.2. Uniject Prefilled Injection System 11.16.3. Uterine Balloon Tamponade 11.16.4. Other 11.17. ASEAN Postpartum Haemorrhage Treatment Device Market Forecast, by Application 11.17.1. Hospitals 11.17.2. Clinics 11.17.3. Other 11.18. Rest of Asia Pacific Postpartum Haemorrhage Treatment Device Market Forecast, by Types 11.18.1. Non-pneumatic Anti-shock Garment 11.18.2. Uniject Prefilled Injection System 11.18.3. Uterine Balloon Tamponade 11.18.4. Other 11.19. Rest of Asia Pacific Postpartum Haemorrhage Treatment Device Market Forecast, by Application 11.19.1. Hospitals 11.19.2. Clinics 11.19.3. Other 11.20. Asia Pacific Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis 11.20.1. By Types 11.20.2. By Application 11.21. PEST Analysis 12. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Analysis 12.1. Key Findings 12.2. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Overview 12.3. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Types 12.4. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Types 12.4.1. Non-pneumatic Anti-shock Garment 12.4.2. Uniject Prefilled Injection System 12.4.3. Uterine Balloon Tamponade 12.4.4. Other 12.5. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Application 12.6. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Application 12.6.1. Hospitals 12.6.2. Clinics 12.6.3. Other 12.7. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Country 12.8. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Country 12.8.1. GCC 12.8.2. South Africa 12.8.3. Rest of Middle East & Africa 12.9. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Analysis, by Country/ Sub-region 12.10. GCC Postpartum Haemorrhage Treatment Device Market Forecast, by Types 12.10.1. Non-pneumatic Anti-shock Garment 12.10.2. Uniject Prefilled Injection System 12.10.3. Uterine Balloon Tamponade 12.10.4. Other 12.11. GCC Postpartum Haemorrhage Treatment Device Market Forecast, by Application 12.11.1. Hospitals 12.11.2. Clinics 12.11.3. Other 12.12. South Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Types 12.12.1. Non-pneumatic Anti-shock Garment 12.12.2. Uniject Prefilled Injection System 12.12.3. Uterine Balloon Tamponade 12.12.4. Other 12.13. South Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Application 12.13.1. Hospitals 12.13.2. Clinics 12.13.3. Other 12.14. Rest of Middle East & Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Types 12.14.1. Non-pneumatic Anti-shock Garment 12.14.2. Uniject Prefilled Injection System 12.14.3. Uterine Balloon Tamponade 12.14.4. Other 12.15. Rest of Middle East & Africa Postpartum Haemorrhage Treatment Device Market Forecast, by Application 12.15.1. Hospitals 12.15.2. Clinics 12.15.3. Other 12.16. Middle East & Africa Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis 12.16.1. By Types 12.16.2. By Application 12.17. PEST Analysis 13. South America Postpartum Haemorrhage Treatment Device Market Analysis 13.1. Key Findings 13.2. South America Postpartum Haemorrhage Treatment Device Market Overview 13.3. South America Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Types 13.4. South America Postpartum Haemorrhage Treatment Device Market Forecast, by Types 13.4.1. Non-pneumatic Anti-shock Garment 13.4.2. Uniject Prefilled Injection System 13.4.3. Uterine Balloon Tamponade 13.4.4. Other 13.5. South America Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Application 13.6. South America Postpartum Haemorrhage Treatment Device Market Forecast, by Application 13.6.1. Hospitals 13.6.2. Clinics 13.6.3. Other 13.7. South America Postpartum Haemorrhage Treatment Device Market Value Share Analysis, by Country 13.8. South America Postpartum Haemorrhage Treatment Device Market Forecast, by Country 13.8.1. Brazil 13.8.2. Mexico 13.8.3. Rest of South America 13.9. South America Postpartum Haemorrhage Treatment Device Market Analysis, by Country/ Sub-region 13.10. Brazil Postpartum Haemorrhage Treatment Device Market Forecast, by Types 13.10.1. Non-pneumatic Anti-shock Garment 13.10.2. Uniject Prefilled Injection System 13.10.3. Uterine Balloon Tamponade 13.10.4. Other 13.11. Brazil Postpartum Haemorrhage Treatment Device Market Forecast, by Application 13.11.1. Hospitals 13.11.2. Clinics 13.11.3. Other 13.12. Mexico Postpartum Haemorrhage Treatment Device Market Forecast, by Types 13.12.1. Non-pneumatic Anti-shock Garment 13.12.2. Uniject Prefilled Injection System 13.12.3. Uterine Balloon Tamponade 13.12.4. Other 13.13. Mexico Postpartum Haemorrhage Treatment Device Market Forecast, by Application 13.13.1. Hospitals 13.13.2. Clinics 13.13.3. Other 13.14. Rest of South America Postpartum Haemorrhage Treatment Device Market Forecast, by Types 13.14.1. Non-pneumatic Anti-shock Garment 13.14.2. Uniject Prefilled Injection System 13.14.3. Uterine Balloon Tamponade 13.14.4. Other 13.15. Rest of South America Postpartum Haemorrhage Treatment Device Market Forecast, by Application 13.15.1. Hospitals 13.15.2. Clinics 13.15.3. Other 13.16. South America Postpartum Haemorrhage Treatment Device Market Attractiveness Analysis 13.16.1. By Types 13.16.2. By Application 13.17. PEST Analysis 14. Company Profiles 14.1. Market Share Analysis, by Company 14.2. Competition Matrix 14.3. Company Profiles: Key Players 14.3.1. BD 14.3.1.1. Company Overview 14.3.1.2. Financial Overview 14.3.1.3. Business Strategy 14.3.1.4. Recent Developments 14.3.1.5. Manufacturing Footprint 14.3.2. GE Healthcare 14.3.3. Bactiguard 14.3.4. R. Bard 14.3.5. Cook Medical 14.3.6. Davol 14.3.7. 3rd Stone Design 14.3.8. Teleflex Incorporated 14.3.9. Utah Medical Products 14.3.10. Program for Appropriate Technology In Health (Path) 14.3.11. Zoex Niasg 14.3.12. Inpress Technologies 14.3.13. Vitality Medical 14.3.14. Revmedx Inc. 14.3.15. Alydia Health 14.3.16. Sterimed Group 14.3.17. Angiplast 14.3.18. Sara Health Care 14.3.19. Boen Healthcare Co., Ltd 14.3.20. McKesson Medical-Surgical Inc. 15. Primary Key Insights